Table 1. Demographics and clinical characteristics of the patient population which includes the clinical characteristics of new-onset AF patients in comparison to the No-AF group.
| Variables | AF (n = 169) | No-AF (n = 2704) | P-Value |
| Age (yrs, mean ± SD) | 78.93 ± 7.5 | 77.63 ± 7.8 | 0.029 |
| Overlap Syndrome group |
6 (3.5%) | 22 (0.8%) | < 0.001 |
| OSA group | 4 (2.4%) | 56 (2%) | 0.794 |
| COPD group | 44 (26%) | 372 (14%) | < 0.001 |
| Anemia | 37 (22%) | 454 (17%) | 0.087 |
| HF | 54 (32%) | 370 (14%) | < 0.001 |
| CAD | 85 (50%) | 950 (35%) | < 0.001 |
| CKD | 35 (21%) | 237 (9%) | < 0.001 |
| DM | 50 (29.5%) | 664 (24.5%) | 0.142 |
| Obesity | 7 (4%) | 148 (5.5%) | 0.457 |
| Hypertension | 119 (70%) | 1636 (60.5%) | 0.010 |
| Hyperlidemia | 70 (41%) | 950 (35%) | 0.098 |
| CVA | 11 (6.5%) | 175 (6.5%) | 0.985 |
| Valve disorders | 27 (16%) | 217 (8%) | < 0.001 |
AF: Atrial fibrillation; CAD: Coronary artery disease; CKD: Chronic kidney disease; COPD: Chronic obstructive pulmonary disease; CVA: Cerebrovascular disease; DM: Diabetes mellitus; HF: Heart failure; OSA: Obstructive sleep apnea.